Young adults vulnerability to COVID-19 in Brazil: an overview across the country
暂无分享,去创建一个
D. C. de Oliveira | N. Hojo-Souza | C. M. da Silva | D. Guidoni | F. S. Souza | D. L. Guidoni | D. C. R. de Oliveira
[1] G. Wallau,et al. COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence , 2021, Nature Medicine.
[2] Mariana Sardinha Bueno,et al. Rapid spread and high impact of the Variant of Concern P.1 in the largest city of Brazil , 2021, medRxiv.
[3] R. Atun,et al. Effect of socioeconomic inequalities and vulnerabilities on health-system preparedness and response to COVID-19 in Brazil: a comprehensive analysis , 2021, The Lancet Global Health.
[4] Md. Mujibur Rahman,et al. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh , 2021, PloS one.
[5] F. S. D. de Souza,et al. Second wave of COVID-19 in Brazil: younger at higher risk , 2021, European Journal of Epidemiology.
[6] G. Lippi,et al. Sudden rise in COVID-19 case fatality among young and middle-aged adults in the south of Brazil after identification of the novel B.1.1.28.1 (P.1) SARS-CoV-2 strain: analysis of data from the state of Parana , 2021, medRxiv.
[7] C. Franco,et al. Model-based evaluation of transmissibility and reinfection for the P.1 variant of the SARS-CoV-2 , 2021, medRxiv.
[8] Carl A. B. Pearson,et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England , 2021, Science.
[9] T. Wakita,et al. Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan , 2021, Emerging infectious diseases.
[10] Naomi R. Waterlow,et al. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 , 2021, Nature.
[11] H. Graichen. What is the difference between the first and the second/third wave of Covid-19? – German perspective , 2021, Journal of Orthopaedics.
[12] F. S. D. de Souza,et al. On the analysis of mortality risk factors for hospitalized COVID-19 patients: A data-driven study using the major Brazilian database , 2020, medRxiv.
[13] Nazim Madhavji,et al. Organization , 2020, WER.
[14] L. Brammer,et al. Risk Factors for Intensive Care Unit Admission and In-hospital Mortality among Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] M. van der Schaar,et al. Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study , 2020, The Lancet Global Health.
[16] Leora I. Horwitz,et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study , 2020, BMJ.
[17] B. Liang,et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis , 2020, Journal of Infection.
[18] R. Atun,et al. Brazil's unified health system: the first 30 years and prospects for the future , 2019, The Lancet.
[19] S. Siegel,et al. Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.
[20] Diretoria De Geociências,et al. MINISTÉRIO DE PLANEJAMENTO, ORÇAMENTO E COORDENAÇÃO FUNDAÇÃO INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATÍSTICA- IBGE , 1997 .
[21] Stanley Lemeshow,et al. Applied Logistic Regression, Second Edition , 1989 .